Keppra 250 mg
Keppra 250 mg is a medicine authorised by Swissmedic under authorisation number 55297. The authorisation holder is UCB-Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 March 2000 and the authorisation is valid without a time limit. ATC code N03AX14 places the medicine in the group Antiepileptics.
| Authorisation number | 55297 |
|---|---|
| Name | Keppra 250 mg |
| Full name | Keppra 250 mg, comprimés pelliculés |
| Authorisation holder | UCB-Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX14 |
| First authorisation | 29 March 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Keppra 250 mg, comprimés pelliculés | B | 29 March 2000 |
| 4 | Keppra 1000 mg, comprimés pelliculés | B | 29 March 2000 |
| 5 | Keppra 500 mg, comprimés pelliculés | B | 29 March 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 30 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 44 | 30 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 50 | 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 52 | 2 x 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 56 | 20 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 62 | 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 68 | 2 x 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Keppra 250 mg authorised in Switzerland?
Yes. Keppra 250 mg is authorised by Swissmedic under authorisation number 55297, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Keppra 250 mg have?
Keppra 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Keppra 250 mg?
The authorisation holder is UCB-Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.